Trademark Overview
On Tuesday, December 19, 2023, a trademark application was filed for ALLOVIR with the United States Patent and Trademark Office. The USPTO has given the ALLOVIR trademark a serial number of 98321672. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, July 30, 2024. This trademark is owned by Allovir, Inc.. The ALLOVIR trademark is filed in the Pharmaceutical Products category with the following description:
antiviral cell therapy products in the nature of virus-specific T cells; antiviral cell therapy products for restoration and enhancement of patients' immune systems in the nature of T cells; antiviral cell therapy products for restoration and enhancement of patients' immune systems in the nature of virus-specific T cells; antiviral allogeneic cell therapy products in the nature of T cells; antiviral allogeneic cell therapy products in the nature of virus-specific T cells; antiviral cells for medical use; antiviral T cells for medical use; antiviral virus-specific T cells for medical use; antiviral immunotherapeutic agents for restoring viral immunity in immunocompromised patients; antiviral immunotherapeutic agents, namely T cells, for restoring viral immunity in immunocompromised patients; antiviral immunotherapeutic agents, namely allogenic T cells, for restoring viral immunity in immunocompromised patients; antiviral immunotherapeutic agents, namely virus-specific T cells, for resto...
